Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia? Stutterheim J, van der Waarden R, de Groot-Kruseman HA, Sonneveld E, et al. Leukemia 2024 Sep 10. doi: 10.1038/s41375-024-02386.

Read + Share

Amedeo Smart

Independent Medical Education

Stutterheim J, van der Waarden R, de Groot-Kruseman HA, Sonneveld E, et al. Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia? Leukemia 2024 Sep 10. doi: 10.1038/s41375-024-02386.
PMID: 39256602